Skin Incision Adhesive in Pediatrics
Evaluation of Surgiseal as a Topical Emergency Department Skin Incision Adhesive in Pediatrics A Case Series
1 other identifier
interventional
8
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of on-label use of Surgiseal™ Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound closure of the topical skin in children presenting in the Emergency Department (ED).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2012
CompletedFirst Posted
Study publicly available on registry
January 23, 2012
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedResults Posted
Study results publicly available
December 4, 2018
CompletedDecember 4, 2018
August 1, 2017
1.5 years
January 12, 2012
August 29, 2017
November 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Wound Closure
wound closure measured baseline to 14 days
baseline to 14 days
Secondary Outcomes (1)
Adverse Events Related to Wound Closure
14 days
Study Arms (1)
Surgical Glue
EXPERIMENTALSurgiseal
Interventions
Eligibility Criteria
You may qualify if:
- Between the ages of 5 and 18 years of age, inclusive
- Candidate for use of a topical surgical skin adhesive
- Informed consent by a parental guardian
You may not qualify if:
- A wound with evidence of active infection or gangrene or wounds of decubitus etiology
- Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to body fluids or dense natural hair
- Subjects with known hypersensitivity to cyanoacrylate or formaldehyde
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akron Children's Hospital Emergency Department
Akron, Ohio, 44308, United States
MeSH Terms
Conditions
Results Point of Contact
- Title
- Ed Drower
- Organization
- Medline Industries, Inc.
Study Officials
- STUDY DIRECTOR
Ed Drower, MS
Medline Industries
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2012
First Posted
January 23, 2012
Study Start
February 1, 2013
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
December 4, 2018
Results First Posted
December 4, 2018
Record last verified: 2017-08